The Global Drug Discovery Technologies Market is poised to grow at a compound annual growth rate of around 12.2 percent over the next decade to reach approximately $160 billion by 2025, according to a recent report from Research & Markets. Some of the prominent trends that the market is witnessing include growing identification of combinatorial chemistry technology, regulatory initiatives fostering demand for pharmacogenomics technology, proteomics in anticancer drug discovery and human protein microarray for various protein analysis.
Based on technology the market is categorized into pharmacogenomics, high-throughput screening, genomics, bioinformatics, biochips, bioanalytical instruments, nanotechnology, metabolomics and other technologies. Depending on the end users the market is segmented by research institutes, pharmaceutical companies, biotech companies, biopharmaceutical companies and other end users.
Depending on the applications the market is segmented by cardiovascular diseases, cancer Parkinson's disease, central nervous system disorders and other applications.
This industry report analyzes the market estimates and forecasts for all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments and future strategies.
According to Research & Markets, the report provides comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East and Latin America and “is a valuable asset for the existing players, new entrants and the future investors.”
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as United States, Canada, Mexico, United Kingdom, Germany, Spain, France, Italy, China, Brazil, Saudi Arabia and South Africa. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and subsegments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.
